Many Bright Ideas Technologies Inc.
MBGNF
$0.01
$0.000.00%
| Weiss Ratings | MBGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | MBGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | MBGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.85 | |||
| Price History | MBGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 61.29% | |||
| 2-Year Total Return | -90.55% | |||
| 3-Year Total Return | -90.55% | |||
| 5-Year Total Return | -74.09% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | MBGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.01 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Apr 03, 2024 | |||
| 52-Week High Price (Date) | Apr 03, 2024 | |||
| Valuation | MBGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 239.96K | |||
| Enterprise Value | 239.08K | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -8.82% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -1.04 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -5.42 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MBGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 17.26M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MBGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 598 East Kent Avenue South Vancouver, BC V5X 4V6 | |||
| Website | www.medbiogene.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | MBGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | MBGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -388.79% | |||
| Return on Equity | -- | |||
| Income Statement | MBGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -45.10K | |||
| Net Income (TTM) | -52.10K | |||
| Net Income Avl. to Common (TTM) | -52.10K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 28.00% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 33.33% | |||
| Balance Sheet | MBGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 900.00 | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 8.00K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -165.40K | |||
| Current Ratio (Q) | 0.046 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 8.00K | |||
| Total Current Liabilities (Q) | 173.40K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 173.40K | |||
| Total Common Equity (Q) | -165.40K | |||
| Cash Flow | MBGNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | 700.00 | |||
| Levered Free Cash Flow (TTM) | 25.00K | |||
| Cash from Operations (TTM) | 1.00K | |||
